Safety of Exercise and High-dose Salbutamol in Patients With Chronic Obstructive Pulmonary Disease (COPD) Receiving Therapeutic Doses of Indacaterol (QAB 149) and Salmeterol

This study has been completed.

Study NCT00531050 Information provided by Novartis

First Received: September 17, 2007 Last Updated: April 1, 2011 History of Changes

No Study Results Posted on ClinicalTrials.gov for this Study

Study Status:	This study has been completed.
Estimated Study Completion Date:	No date given
Primary Completion Date:	June 2008 (Final data collection date for primary outcome measure)